Actively Recruiting
Bone Remodeling Around a Trabecular Titanium Cup in Total Hip Arthroplasty
Led by Permedica spa · Updated on 2025-09-02
50
Participants Needed
2
Research Sites
216 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this randomized controlled trial is to measure the periprosthetic bone mineral density changes around a 3D-printed highly-porous titanium acetabular cup used in primary total hip arthroplasty compared to a standard hydroxyapatite/titanium plasma-sprayed acetabular cup up to 2-year follow-up.
CONDITIONS
Official Title
Bone Remodeling Around a Trabecular Titanium Cup in Total Hip Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient scheduled for unilateral cementless primary total hip arthroplasty with Jump System Traser�ae or Jump System HAX-Pore�ae cup
- Patient diagnosed with primary or secondary hip osteoarthritis
- Patient has given informed consent
You will not qualify if you...
- Male patients younger than 40 years or older than 85 years
- Female patients younger than 50 years or older than 85 years
- Pregnant or childbearing patients
- Patients not suitable for the investigational devices
- Patients not suitable for cementless metaphyseal short femoral stems by Permedica Orthopaedics (Exacta RS or Exacta S)
- Patients with rheumatoid arthritis, avascular osteonecrosis, severe hip dysplasia (Crowe grade III-IV), Perthes disease, Paget disease, femoral neck fracture, pelvic fracture, or prior hip surgery/trauma sequelae
- Patients with bone disorders
- Patients with diabetes
- Patients on parathyroid hormone, corticosteroid, or osteoporosis treatments
- Patients with disabling disease in the opposite limb
- Patients with body mass index over 30 or under 18
- Patients unwilling or unable to follow or understand the study protocol
- Patients addicted to alcohol or drugs
- Patients already enrolled in other clinical studies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
IRCCS Istituto Clinico San Siro
Milan, Italy, 20148
Actively Recruiting
2
IRCCS Ospedale Galeazzi-Sant'Ambrogio
Milan, Italy, 20161
Actively Recruiting
Research Team
L
Lorenzo Banci, MSc
CONTACT
M
Marta Colombo, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here